Valuation (43%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 37.47 | N/A |
| PEG Ratio (TTM) | 0.37 | N/A |
| P/S Ratio (TTM) | 9.79 | N/A |
| P/B Ratio (TTM) | 8.37 | N/A |
| P/FCF Ratio (TTM) | 40.69 | N/A |
| Price to 5YR AVG Earnings Ratio | 67.06 | N/A |
| Price to 5YR AVG FCF Ratio | 89.35 | N/A |
Profitability (85%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 19.76% | N/A |
| ROE (TTM) | 23.99% | N/A |
| Net Profit Margin (TTM) | 26.12% | N/A |
| ROIC 5YR AVG | 64.07% | N/A |
Growth (80%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 0.60% | 189.10% | 126.97% |
| Revenue | 2.67% | 13.57% | 18.24% |
| Net Income | 0.56% | 182.73% | 123.96% |
| Cash Flow | 72.11% | 29.70% | 22.48% |
Health (67%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 9.21 | N/A |
| Quick Ratio (TTM) | 7.82 | N/A |
| D/E Ratio (TTM) | N/A | N/A |
| Interest Coverage (TTM) | 62.28 | N/A |
| Piotroski F-Score | 4 | N/A |
| Altman Z-Score | 41.97 | N/A |
| LTL to 5YR AVG FCF | 0.41 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.91% | N/A |